Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...
Hosted on MSN
Prostate cancer: The treatment that identifies cancer cells and destroys them from within
In recent decades, there have been enormous developments in cancer treatment. In the past, most patients received chemotherapy, a broad treatment that also damages healthy cells, but for several years ...
Interesting Engineering on MSN
Double trouble for tumors: Immunotherapy shows promise in prostate cancer treatment
Researchers at the University of Arizona Health Sciences have uncovered a promising new approach for treating prostate cancer ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
In a study published July 7 in npj Precision Oncology, University of Michigan researchers at the Department of Internal Medicine and Rogel Cancer Center identified a gene program, or specific set of ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback